Skip to main content
ACH logo

ACH · Accendra Health Inc · Webcasts, Transcripts & Audio

Track ACH — free
$0.02 0.00 (-3.50%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$6.59M
Shares
76.92M
Volume · Nov 18 17.62M Avg daily vol (3M) 2.97M

Accendra Health Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Accendra Health Inc (ACH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-05
Accendra Health Inc (ACH) Q3 2026 Earnings Call Transcript
Balanced tone Financial outlook and 2026 underperformance Commercial payer loss and category declines Liquidity and balance sheet
Revenue
$601.77M
▼ 13.7% YoY
Diluted EPS
$-0.25
Gross margin
43.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-10
Accendra Health Inc (ACH) Q2 2026 Earnings Call Transcript
Positive tone Cost reduction and efficiency initiatives CEO retirement and leadership transition Sleep center of excellence rollout
Revenue
$613.23M
▼ 10.1% YoY
Diluted EPS
$-1.16
Gross margin
43.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-11
Accendra Health Inc (ACH) Q1 2026 Earnings Call Transcript
Confident tone Large commercial payor exit Sleep therapy growth initiatives Balance sheet optimization / debt refinancing
Revenue
$627.78M
▼ 6.8% YoY
Diluted EPS
$-0.08
Gross margin
44.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
Accendra Health Inc (ACH) Q4 2025 Earnings Call Transcript
Confident tone Capital structure and debt reduction Loss of large commercial payer and stranded costs Sleep category growth
Revenue
$708.97M*
Gross margin
45.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Accendra Health Inc (ACH) Q3 2025 Earnings Call Transcript
Confident tone Loss of large customer (Kaiser) contract Patient Direct home-based care strategy Optum preferred provider agreement
Revenue
$697.26M
▲ 1.5% YoY
Diluted EPS
$-1.94
Gross margin
46.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Accendra Health Inc (ACH) Q2 2025 Earnings Call Transcript
Positive tone Patient Direct strategic focus and divestiture of P&HS Q2 financial results and revenue growth Stranded costs and post-divestiture cost structure
Revenue
$681.92M
▲ 3.3% YoY
Diluted EPS
$-11.30
Gross margin
47.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Accendra Health Inc (ACH) Q1 2025 Earnings Call Transcript
Positive tone Patient Direct segment performance Rotech acquisition Medical Distribution and proprietary products
Revenue
$673.88M
▼ 74.2% YoY
Diluted EPS
$-0.32
Gross margin
78.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Accendra Health Inc (ACH) Q4 2024 Earnings Call Transcript
Positive tone Patient Direct segment performance and growth Rotech acquisition and regulatory clearance Share repurchase program
Revenue
−$1.28B*
Gross margin
-45.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Accendra Health Inc (ACH) Q3 2024 Earnings Call Transcript
Confident tone Patient Direct growth in sleep and diabetes Rotech acquisition Products and Healthcare Services segment performance
Revenue
$686.85M
▼ 73.5% YoY
Diluted EPS
$-0.16
Gross margin
81.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
Accendra Health Inc (ACH) Q2 2024 Earnings Call Transcript
Confident tone Patient Direct Segment Growth Cash Flow and Working Capital Products & Healthcare Services Segment Performance
Revenue
$660.40M
▼ 74.2% YoY
Diluted EPS
$-0.42
Gross margin
82.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Accendra Health Inc (ACH) Q1 2024 Earnings Call Transcript
Positive tone Patient Direct segment performance and reimbursement Free cash flow and balance sheet Gross margin expansion
Revenue
$2.61B
▲ 3.6% YoY
Diluted EPS
$-0.29
Gross margin
20.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Accendra Health Inc (ACH) Q4 2023 Earnings Call Transcript
Confident tone Patient Direct segment growth 2024 financial guidance LIFO and stock comp normalization in adjusted EBITDA
Revenue
−$5.13B*
▼ 300.9% YoY
Gross margin
-11.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Accendra Health Inc (ACH) Q3 2023 Earnings Call Transcript
Revenue
$2.59B
▲ 3.8% YoY
Diluted EPS
$-0.08
▼ 150% YoY
Gross margin
20.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-04
Accendra Health Inc (ACH) Q2 2023 Earnings Call Transcript
Revenue
$2.56B
▲ 2.5% YoY
Diluted EPS
$-0.37
▼ 200% YoY
Gross margin
20.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
Accendra Health Inc (ACH) Q1 2023 Earnings Call Transcript
Revenue
$2.52B
▲ 4.8% YoY
Diluted EPS
$-0.32
▼ 161.5% YoY
Gross margin
19.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Accendra Health Inc (ACH) Q4 2022 Earnings Call Transcript
Revenue
$2.55B*
▲ 3.4% YoY
Gross margin
16.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Accendra Health Inc (ACH) Q3 2022 Earnings Call Transcript
Revenue
$2.50B
▼ 0.2% YoY
Diluted EPS
$0.16
▼ 72.4% YoY
Gross margin
20.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Accendra Health Inc (ACH) Q2 2022 Earnings Call Transcript
Revenue
$2.50B
▲ 0.4% YoY
Diluted EPS
$0.37
▼ 57.5% YoY
Gross margin
21.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Accendra Health Inc (ACH) Q1 2022 Earnings Call Transcript
Revenue
$2.41B
▲ 3.5% YoY
Diluted EPS
$0.52
▼ 46.9% YoY
Gross margin
15.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Accendra Health Inc (ACH) Q4 2021 Earnings Call Transcript
Revenue
$2.47B*
▲ 4.5% YoY
Gross margin
13.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Accendra Health Inc (ACH) Q3 2021 Earnings Call Transcript
Revenue
$2.50B
▲ 14.4% YoY
Diluted EPS
$0.58
▼ 23.7% YoY
Gross margin
13.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Accendra Health Inc (ACH) Q2 2021 Earnings Call Transcript
Revenue
$2.49B
▲ 37.7% YoY
Diluted EPS
$0.87
Gross margin
16.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Accendra Health Inc (ACH) Q1 2021 Earnings Call Transcript
Revenue
$2.33B
▲ 9.6% YoY
Diluted EPS
$0.98
Gross margin
19.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Accendra Health Inc (ACH) Q4 2020 Earnings Call Transcript
Revenue
$2.36B*
▲ 7.8% YoY
Gross margin
16.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Accendra Health Inc (ACH) Q3 2020 Earnings Call Transcript
Revenue
$2.19B
▼ 4.6% YoY
Diluted EPS
$0.76
Gross margin
15.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-09-24
Accendra Health Inc (ACH) Q2 2020 Earnings Call Transcript
Revenue
$1.81B
▼ 23.9% YoY
Diluted EPS
$-0.91
Gross margin
14.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Accendra Health Inc (ACH) Q1 2020 Earnings Call Transcript
Revenue
$2.12B
▼ 9.7% YoY
Gross margin
12.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-04
Accendra Health Inc (ACH) Q4 2019 Earnings Call
Revenue
$2.19B*
▲ 3.2% YoY
Gross margin
13.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 75252 CUSIP 690732102 13F (30d) 147 filings 111 filers Visit website Investor relations